drugset / Trial / NCT04720183
Drug-drug Interaction Study with GLPG3970 and Sulfasalazine in Adult, Healthy Subjects
NaSequentialOpen-labelBasic science
Summary
GLPG3970 will be given with sulfasalazine to investigate the effect of co-administration on the pharmacokinetics of sulfasalazine, and on the safety and tolerability of the drugs in healthy adult subjects.
Timeline
- Start
- 2021-01-11
- Primary completion
- 2021-04-21
- Completion
- 2021-04-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GLPG3970 | Unknown | — | Oral |
| Subject | Sulfasalazine | Small molecule | — | Oral |
Indications
No indication recorded.